Filing Details
- Accession Number:
- 0001209191-10-061374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-17 15:54:31
- Reporting Period:
- 2010-12-16
- Filing Date:
- 2010-12-17
- Accepted Time:
- 2010-12-17 15:54:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 59478 | Lilly Eli & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1430788 | D. Bryce Carmine | Lilly Corporate Center Indianapolis IN 46285 | Evp And Pres, Lilly Bio-Meds | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-12-06 | 45 | $0.00 | 63,295 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2010-12-07 | 60 | $0.00 | 63,235 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2010-12-09 | 105 | $0.00 | 63,130 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2010-12-16 | 3,100 | $35.10 | 60,030 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Direct | |
| No | 4 | G | Direct | |
| No | 4 | G | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,085 | Indirect | 401(k) |
Footnotes
- The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010.
Billionaire Hedge Funds
